Andreas Clemens - Concepedia

Author

Andreas Clemens

Also Known As

A Clemens, A. B. Clemens, A. CLEMENS, A. Clemens, Andreas Clemens, Andreas Clemens (575143), Angela Clemens, Clemens A, Clemens, A., Francesco Patalano

190

Publications

7.8K

Citations

H-Index

118

Concepts

All Affiliations

Boehringer Ingelheim (Germany)Novartis (Switzerland)University of Freiburg Heidelberg University Johannes Gutenberg University Mainz

About

Andreas Clemens is an author at Boehringer Ingelheim (Germany) specializing in medicine, cardiovascular disease, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	29	1.9K
2	Public Health	7	7	799
3	Health Sciences	5	5	135
4	Engineering	3	3	111
5	Social Sciences	1	1	21

Andreas Clemens

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients Arlene M. Gallagher, Efrosini Setakis, Jonathan Plumb, Thrombosis and Haemostasis	2011	348
Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control Christopher Ll. Morgan, Phil McEwan, Andrzej Tukiendorf, Thrombosis Research Warfarin TreatmentThrombosisCardiovascular DiseaseMedicineClinical Epidemiology	2008	295
The Artificial Beta Cell - A Continuous Control of Blood Sugar by External Regulation of Insulin Infusion (Glucose Controlled Insulin Infusion System) E. F. Pfeiffer, Ch. Thum, Andreas Clemens Hormone and Metabolic Research Diabetes ManagementInsulin ManagementPhysiologyDiabetesFood Intake	1974	233
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Frederikus A. Klok, Volker Hösel, Andreas Clemens, European Respiratory Journal	2016	224
Effective elimination of dabigatran by haemodialysis Harm Peters, Andreas Clemens Thrombosis and Haemostasis	2013	204
Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Michael D. Ezekowitz, Rangadham Nagarakanti, Herbert Noack, Circulation	2016	164
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation Menno V. Huisman, Gregory Y.H. Lip, Hans‐Christoph Diener, American Heart Journal ThrombosisGlobal Registry ProgramVenous ThrombosisCardiovascular DiseasePatient Safety	2013	147
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference Paulus Kirchhof, G. Breithardt, E Aliot, EP Europace Heart FailureAcute Myocardial InfarctionThrombosisElectrophysiological EvaluationPersonalized Management	2013	140
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: A pooled analysis of three trials Richard J. Friedman, O.E. Dahl, Nadia Rosencher, Thrombosis Research ThrombosisDabigatran Versus EnoxaparinVenous ThrombosisOrthopaedicsPharmacotherapy	2010	138
Prognostic value of codon 918 (ATG?ACG)RET proto-oncogene mutations in sporadic medullary thyroid carcinoma Tobias Schilling, Julia B�rck, Hans‐Peter Sinn, International Journal of Cancer	2001	137

Page 1